About Geluk Pharma Private Limited
Data last updated:
Geluk Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 28 September 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2015PTC268740. Its GSTIN is 27AAGCG1271Q1Z6 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Siba Prasad Maitra and Dhruv Dilip Mehta.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 105 New Udyog Mandir – 2 Mughal Lane Mahim, Mumbai, Maharashtra, India – 400016.
As per the financials filed for FY 2021, the company reported a revenue of ₹3.43 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.05 Cr (net margin 88.9%) and EBITDA of ₹3.05 Cr (EBITDA margin 88.9%).
The company has about 2 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Geluk Pharma.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gelukpharma.com.
Company details
Contact details
Geluk Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is gelukpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address105 New Udyog Mandir – 2 Mughal Lane Mahim, Mumbai, Maharashtra, India – 400016
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Geluk Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Geluk Pharma operates one associated brand: Geluk Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and provides Indian traditional pharmaceuticals focused on topical dermatological treatments. | gelukpharma.com |
Business activity
The main business activity of Geluk Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Geluk Pharma Private Limited, buy the company report.
Financials of Geluk Pharma Private Limited
FY 2021 filings availableGeluk Pharma Private Limited reported revenue of ₹3.43 Cr (up 1457% YoY) for FY 2021.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.05 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.05 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 88.9% | ||||
| Net Profit Margin | 88.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Geluk Pharma Private Limited, buy the company report.
Board of directors of Geluk Pharma Private Limited
Geluk Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siba Prasad Maitra Also directs: Abinitio Solutions Private Limited | Director | 28 Sep 2015 | 11 Years 1 Months | Current |
| Dhruv Dilip Mehta | Additional Director | 04 Apr 2019 | 7 Years 6 Months | Current |
Peer comparison
Geluk Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Seamac Formulations Private Limited | ₹3.44 Cr (FY 2024) | 7.0% | Talwara, Punjab, India | |||
| Genip Formulations Private Limited | ₹3.44 Cr (FY 2025) | 512.0% | Hyderabad, Telangana, India | |||
| Rajdhani Chemicals P. Ltd. | ₹3.43 Cr (FY 2024) | 138.0% | Hyderabad, Telangana, India | |||
| Geluk Pharma Private Limitedthis company | ₹3.43 Cr (FY 2021) | ₹3.05 Cr | 88.9% | 1457.0% | 2 | Mumbai, Maharashtra, India |
| Ashahi Chemical Industries Private Limited | ₹3.42 Cr (FY 2024) | -41.0% | Mehsana, Gujarat, India |
To see the full peer comparison of Geluk Pharma Private Limited, buy the company report.
Auditor
Geluk Pharma Private Limited is audited by RAVI H DASIJA AND COMPANY for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVI H DASIJA AND COMPANY | FY 2019 | 138346W |
Shareholding
The shareholding of Geluk Pharma Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Geluk Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Geluk Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Geluk Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Geluk Pharma Private Limited has a workforce of 2 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
GST
Geluk Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCG1271Q1Z6 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Geluk Pharma Private Limited, buy the company report.
Recent activity
Geluk Pharma Private Limited has 4 board changes on record since 2015: 3 appointments and 1 cessation. The latest: Dilip Amichand Mehta ceased to be Director on 14 Jun 2019.
Frequently asked questions
Geluk Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 28 September 2015 (11+ years old) and is registered under CIN U24233MH2015PTC268740.
Geluk Pharma has 2 current directors:
- Siba Prasad Maitra - Director
- Dhruv Dilip Mehta - Additional Director
The latest financial statements of Geluk Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Geluk Pharma is 27AAGCG1271Q1Z6, registered in Maharashtra.
The CIN (Corporate Identification Number) of Geluk Pharma is U24233MH2015PTC268740. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Geluk Pharma was incorporated on 28 September 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Geluk Pharma by revenue are Seamac Formulations Private Limited, Genip Formulations Private Limited, Rajdhani Chemicals P. Ltd, Ashahi Chemical Industries Private Limited, all in the Chemicals industry (Formulations, Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dilip Amichand Mehta ceased to be Director on 14 Jun 2019. Dhruv Dilip Mehta was appointed as Additional Director on 04 Apr 2019. Dilip Amichand Mehta was appointed as Director on 28 Sep 2015. Geluk Pharma has 4 board changes on record in total.
Geluk Pharma can be reached through the website gelukpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Geluk Pharma is at 105 New Udyog Mandir – 2 Mughal Lane Mahim, Mumbai, Maharashtra, India – 400016.
Geluk Pharma operates in the chemicals and materials industry, in the industrial chemicals segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
